A large trial found no reduction in cancer or cardiovascular events overall, with only subtle possible signals.
What the evidence shows
Low vitamin D is associated with many diseases, so supplements were widely expected to prevent cancer and heart disease. But low vitamin D might be a consequence of poor health (people who are ill go outside less), not a cause — only a randomized trial can tell.
The VITAL trial (Manson et al., 2019) randomized nearly 26,000 US adults to vitamin D or placebo for about five years. It found no significant reduction in the primary outcomes of invasive cancer or major cardiovascular events. Some secondary analyses hinted at a possible reduction in cancer deaths over longer follow-up, keeping the door open, but the headline preventive claims were not confirmed. For people who are not deficient, routine high-dose vitamin D to prevent cancer or heart disease is not supported; correcting genuine deficiency is a separate, valid use.
Sources
Manson, J. E., Cook, N. R., Lee, I.-M., et al. (2019). Vitamin D supplements and prevention of cancer and cardiovascular disease (VITAL).
New England Journal of Medicine, 380(1), 33–44
Vitamin D did not significantly lower the incidence of invasive cancer or major cardiovascular events versus placebo.
DOI: 10.1056/NEJMoa1809944 →